Covalently Induced Activation of the δ Opioid Receptor by a Fluorogenic Affinity Label, 7‘-(Phthalaldehydecarboxamido)naltrindole (PNTI)
- 28 February 2001
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (7) , 1017-1020
- https://doi.org/10.1021/jm010004u
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Chloroethylclonidine and 2-Aminoethyl Methanethiosulfonate Recognize Two Different Conformations of the Human α2A-Adrenergic ReceptorJournal of Biological Chemistry, 1999
- Synthesis, Opioid Receptor Binding, and Bioassay of Naltrindole Analogues Substituted in the Indolic Benzene MoietyJournal of Medicinal Chemistry, 1998
- Constitutive Activation of the β2 Adrenergic Receptor Alters the Orientation of Its Sixth Membrane-spanning SegmentPublished by Elsevier ,1997
- Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of RhodopsinScience, 1996
- Selective Natrexone-Derived Opioid Receptor AntagonistsAnnual Review of Pharmacology and Toxicology, 1992
- Binaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonistsLife Sciences, 1987
- Design of DNA-binding peptides: stabilization of .alpha.-helical structure by DNAJournal of the American Chemical Society, 1985
- TENA, a selective kappa opioid receptor antagonistLife Sciences, 1985
- The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexoneEuropean Journal of Pharmacology, 1981
- Emission spectroscopy and state ordering of retinalsJournal of the American Chemical Society, 1976